|
CCDC111 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.280270E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.956100E-03 |
| Normal-vs-Stage2 |
7.884500E-02 |
| Normal-vs-Stage3 |
3.940600E-03 |
| Normal-vs-Stage4 |
2.137900E-03 |
| Stage1-vs-Stage2 |
7.305000E-01 |
| Stage1-vs-Stage3 |
3.931200E-01 |
| Stage1-vs-Stage4 |
2.486400E-01 |
| Stage2-vs-Stage3 |
2.792000E-01 |
| Stage2-vs-Stage4 |
9.456500E-02 |
| Stage3-vs-Stage4 |
5.180200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.081500E-02 |
| Normal-vs-AfricanAmerican |
1.210480E-04 |
| Normal-vs-Asian |
3.212400E-02 |
| Caucasian-vs-AfricanAmerican |
2.181800E-03 |
| Caucasian-vs-Asian |
3.375000E-01 |
| AfricanAmerican-vs-Asian |
8.898400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.447700E-02 |
| Normal-vs-Female |
3.423600E-01 |
| Male-vs-Female |
4.675700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.898300E-03 |
| Normal-vs-Extreme_Weight |
2.987600E-02 |
| Normal-vs-Obese |
9.260000E-02 |
| Normal-vs-Extreme_Obese |
1.687760E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.450800E-01 |
| Normal_Weight-vs-Obese |
2.258800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.266400E-01 |
| Extreme_Weight-vs-Obese |
7.844200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.162400E-01 |
| Obese-vs-Extreme_Obese |
3.141000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.198380E-01 |
| Normal-vs-Age(41-60Yrs) |
5.176000E-02 |
| Normal-vs-Age(61-80Yrs) |
1.356010E-02 |
| Normal-vs-Age(81-100Yrs) |
1.215700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.252600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.474400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.452600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.577200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.389400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.299200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.172200E-01 |
| Normal-VS-Type2 PRCC |
1.7318399999966E-05 |
| Normal-VS-KIRP CIMP |
1.216470E-02 |
| Normal-VS-Unclassified PRCC |
2.856600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.58511999999167E-05 |
| Type1 PRCC-VS-KIRP CIMP |
1.387010E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.342600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.114800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.560600E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.831420E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.54579999999527E-05 |
| Normal-vs-N1 |
6.108000E-02 |
| Normal-vs-N2 |
1.613780E-02 |
| N0-vs-N1 |
5.663800E-01 |
| N0-vs-N2 |
4.756000E-01 |
| N1-vs-N2 |
1.501430E-01 |
|
|
